Wolverine Trading, LLC Bristol Myers Squibb CO Transaction History

Wolverine Trading, LLC

$103 Billion
Q4 2024

A detailed history of Wolverine Trading, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wolverine Trading, LLC holds 69,543 shares of BMY stock, worth $3.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,543

Previous 90,051 22.77%

Holding current value

$3.88 Million

Previous $4.66 Million 15.6%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$51.92 - $59.94 $1.06 Million - $1.23 Million	-20,508 Reduced 22.77%	69,543 $3.93 Million
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $1.33 Million - $1.74 Million	33,589 Added 59.49%	90,051 $4.66 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $1.65 Million - $2.17 Million	-40,888 Reduced 42.0%	56,462 $2.34 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $3.42 Million - $3.87 Million	71,188 Added 272.1%	97,350 $5.28 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $3.22 Million - $3.84 Million	-66,410 Reduced 71.74%	26,162 $1.34 Million
Q3 2023 Nov 15, 2023	BUY	$57.89 - $64.73 $1.32 Million - $1.48 Million	22,826 Added 32.73%	92,572 $5.37 Million
Q2 2023 Aug 23, 2023	BUY	$63.71 - $70.74 $4.44 Million - $4.93 Million	69,746 New	69,746 $4.46 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $1.37 Million - $1.6 Million	25,622 Added 63.88%	65,733 $4.11 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $2.47 Million - $2.89 Million	-41,723 Reduced 50.98%	40,111 $2.43 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $3.74 Million - $4.21 Million	-63,040 Reduced 43.51%	81,834 $5.18 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $7.58 Million - $8.59 Million	131,275 Added 965.33%	144,874 $8.97 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $1.11 Million - $1.23 Million	-19,291 Reduced 58.65%	13,599 $815,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $3.69 Million - $4.31 Million	-67,253 Reduced 67.16%	32,890 $1.9 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $3.22 Million - $4.68 Million	-69,373 Reduced 40.92%	100,143 $5.45 Million
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $1.19 Million - $1.56 Million	-24,269 Reduced 12.52%	169,516 $10.8 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $1.45 Million - $1.72 Million	-33,989 Reduced 14.92%	193,785 $9.73 Million
Q2 2019 Aug 20, 2019	SELL	$44.62 - $49.34 $229,971 - $254,298	-5,154 Reduced 2.21%	227,774 $10.3 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $6.55 Million - $7.81 Million	145,158 Added 165.38%	232,928 $11.1 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $3.47 Million - $4.5 Million	71,230 Added 430.65%	87,770 $4.47 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $3.3 Million - $3.72 Million	-59,827 Reduced 78.34%	16,540 $1.03 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $2.97 Million - $3.42 Million	-49,512 Reduced 39.33%	76,367 $4.83 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $6.63 Million - $7.23 Million	110,641 Added 726.09%	125,879 $7.71 Million
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $841,594 - $971,270	15,238	15,238 $971,000

Others Institutions Holding BMY

# of Institutions

2,749

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Bristol Myers Squibb CO Transaction History